Related Experiment Video
Updated: Aug 20, 2025

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
Published on: September 27, 2019
Pruritus in Chronic Liver Disease
1Division of Gastroenterology and Hepatology, Henry Ford Health System, 2799 W Grand Boulevard, Detroit, MI 48202, USA.
Pruritus, or itching, is common in chronic liver disease. Treatment options range from cholestyramine to alternative therapies like rifampicin or experimental procedures if initial treatments fail.
Area of Science:
- Hepatology
- Dermatology
- Pharmacology
Background:
- Pruritus is a common symptom in chronic liver disease, especially cholestatic forms.
- The exact causes of pruritus in liver disease are not fully understood.
- Diagnosis requires ruling out other potential causes like skin, nerve, or psychological disorders.
Purpose of the Study:
- To review the current understanding and management of pruritus associated with chronic liver disease.
- To outline diagnostic workup and therapeutic strategies for liver disease-related pruritus.
Main Methods:
- Literature review of proposed pathophysiological mechanisms.
- Summary of diagnostic approaches to exclude other causes of pruritus.
- Overview of established and experimental treatment options.
Main Results:
- Cholestyramine is the recommended first-line treatment and is often effective.
- Rifampicin and μ-opioid receptor antagonists are alternatives for refractory cases.
- Experimental therapies including albumin dialysis and photopheresis may be considered for severe, intractable pruritus.
Conclusions:
- Management of pruritus in liver disease involves a stepwise approach.
- Effective treatment options exist, but further research into pathophysiology is needed.
- A range of therapies, from medication to advanced procedures, can be employed based on severity and response.
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Kidney Disease II: Clinical Manifestations
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Pancreatitis II: Collaborative Care
Assessment:

